Osaic Holdings
ABBV icon

Osaic Holdings’s AbbVie ABBV Stock Holding History

Osaic Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$158M Buy
726,921
+4,308
+0.6% +$956K 0.23% 75
2025
Q4 		$165M Sell
722,613
-11,827
-2% -$2.69M 0.24% 72
2025
Q3 		$163M Buy
734,440
+91,979
+14% +$18.7M 0.23% 79
2025
Q2 		$121M Buy
642,461
+91,364
+17% +$17M 0.22% 85
2025
Q1 		$116M Buy
551,097
+15,809
+3% +$3.07M 0.26% 71
2024
Q4 		$89.7M Sell
535,288
-10,679
-2% -$1.96M 0.2% 97
2024
Q3 		$108M Sell
545,967
-39,135
-7% -$7.3M 0.24% 78
2024
Q2 		$100M Sell
585,102
-52,513
-8% -$8.7M 0.24% 80
2024
Q1 		$116M Sell
637,615
-286,077
-31% -$49.3M 0.26% 76
2023
Q4 		$143M Sell
923,692
-284,843
-24% -$41.5M 0.25% 85
2023
Q3 		$180M Buy
1,208,535
+234,179
+24% +$34.4M 0.27% 82
2023
Q2 		$131M Sell
974,356
-57,827
-6% -$8.48M 0.24% 88
2023
Q1 		$165M Sell
1,032,183
-440
-0% -$67.3K 0.31% 65
2022
Q4 		$167M Buy
1,032,623
+50,137
+5% +$7.69M 0.34% 55
2022
Q3 		$132M Buy
982,486
+43,508
+5% +$6.24M 0.3% 64
2022
Q2 		$144M Sell
938,978
-46,507
-5% -$7.11M 0.32% 61
2022
Q1 		$151M Sell
985,485
-1,797
-0.2% -$261K 0.29% 61
2021
Q4 		$134M Buy
987,282
+412
+0% +$48.7K 0.25% 79
2021
Q3 		$107M Buy
986,870
+49,650
+5% +$5.67M 0.22% 92
2021
Q2 		$106M Buy
937,220
+37,128
+4% +$4.18M 0.23% 90
2021
Q1 		$97.5M Buy
900,092
+68,155
+8% +$7.29M 0.23% 90
2020
Q4 		$89.2M Buy
831,937
+44,911
+6% +$4.32M 0.24% 91
2020
Q3 		$69.2M Sell
787,026
-9,611
-1% -$905K 0.21% 103
2020
Q2 		$78.2M Sell
796,637
-1,628,578
-67% -$143M 0.26% 79
2020
Q1 		$57.3M Buy
+2,425,215
New +$207M 0.23% 88

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Osaic Holdings's ABBV Position: Q1 2026 in Review

Osaic Holdings increased its AbbVie (ABBV) stake by 0.6% in Q1 2026, buying an estimated $956K and bringing the position to 726,921 shares worth $158M. The position accounts for 0.23% of the portfolio, ranked #75.

Osaic Holdings first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $180M in Q3 2023. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Osaic Holdings held 726,921 shares of AbbVie worth $158M as of Q1 2026.
  • Osaic Holdings bought 4,308 AbbVie shares in Q1 2026, an estimated $956K.
  • AbbVie made up 0.23% of Osaic Holdings's portfolio in Q1 2026, its #75 holding.
  • Osaic Holdings first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's AbbVie position peaked at $180M in Q3 2023.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.